日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer

利用患者来源的异种移植模型建立胆道癌精准肿瘤学模型

Timothy P DiPeri, Kurt W Evans, Stephen Scott, Xiaofeng Zheng, Kaushik Varadarajan, Lawrence N Kwong, Michael Kahle, Hop S Tran Cao, Ching-Wei Tzeng, Thuy Vu, Sunhee Kim, Fei Su, Maria Gabriela Raso, Yasmeen Rizvi, Ming Zhao, Huamin Wang, Sunyoung S Lee, Timothy A Yap, Jordi Rodon, Milind Javle, Fun

Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

ATR激酶抑制剂Elimusertib单药或联合治疗对具有DNA损伤反应通路和其他基因组改变的肿瘤的疗效

Varadarajan Kaushik, Cruz Pico Christian X, Evans Kurt W, Raso Maria Gabriela, Rizvi Yasmeen Qamar, Zheng Xiaofeng, Chachad Dhruv, DiPeri Timothy P, Wang Bailiang, Scott Stephen M, Zhao Ming, Akcakanat Argun, Wengner Antje M, Yap Timothy A, Meric-Bernstam Funda

Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts

新型双特异性抗HER2抗体Zanidatamab在患者来源异种移植模型中的联合临床试验

DiPeri, Timothy P; Evans, Kurt W; Wang, Bailiang; Zhao, Ming; Akcakanat, Argun; Raso, Maria Gabriela; Rizvi, Yasmeen Q; Zheng, Xiaofeng; Korkut, Anil; Varadarajan, Kaushik; Uzunparmak, Burak; Dumbrava, Ecaterina E; Pant, Shubham; Ajani, Jaffer A; Pohlmann, Paula R; Jensen, V Behrana; Javle, Milind; Rodon, Jordi; Meric-Bernstam, Funda

Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.

MAPK通路趋同改变介导FGFR2融合阳性胆管癌对FGFR抑制剂的获得性耐药

DiPeri Timothy P, Zhao Ming, Evans Kurt W, Varadarajan Kaushik, Moss Tyler, Scott Stephen, Kahle Michael P, Byrnes Charnel C, Chen Huiqin, Lee Sunyoung S, Halim Abdel-Baset, Hirai Hiroshi, Wacheck Volker, Kwong Lawrence N, Rodon Jordi, Javle Milind, Meric-Bernstam Funda

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers

Adavosertib 增强 Trastuzumab Deruxtecan 在 HER2 表达癌症中的抗肿瘤活性

Timothy P DiPeri, Kurt W Evans, Maria Gabriela Raso, Ming Zhao, Yasmeen Q Rizvi, Xiaofeng Zheng, Bailiang Wang, Bryce P Kirby, Kathleen Kong, Michael Kahle, Timothy A Yap, Ecaterina E Dumbrava, Jaffer A Ajani, Siqing Fu, Khandan Keyomarsi, Funda Meric-Bernstam

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan

表观遗传上调 TROP2 和 SLFN11 可增强 TROP2 抗体药物偶联物 sacitizumab govitecan 的治疗效果

Ming Zhao, Timothy P DiPeri, Maria Gabriela Raso, Xiaofeng Zheng, Yasmeen Qamar Rizvi, Kurt W Evans, Fei Yang, Argun Akcakanat, Marco Roberto Estecio, Debu Tripathy, Ecaterina E Dumbrava, Senthil Damodaran, Funda Meric-Bernstam

Discordance of HER2 Expression and/or Amplification on Repeat Testing

重复检测中HER2表达和/或扩增不一致

DiPeri, Timothy P; Kong, Kathleen; Varadarajan, Kaushik; Karp, Daniel D; Ajani, Jaffer A; Pant, Shubham; Press, Michael F; Piha-Paul, Sarina A; Dumbrava, Ecaterina E; Meric-Bernstam, Funda

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

不可逆成纤维细胞生长因子受体抑制剂富巴替尼在FGFR改变的乳腺癌中的疗效

Turcin Saridogan ,Argun Akcakanat ,Ming Zhao ,Kurt W Evans ,Erkan Yuca ,Stephen Scott ,Bryce P Kirby ,Xiaofeng Zheng ,Min Jin Ha ,Huiqin Chen ,Patrick K S Ng ,Timothy P DiPeri ,Gordon B Mills ,Jordi Rodon Ahnert ,Senthil Damodaran ,Funda Meric-Bernstam

Total neoadjuvant therapy for locally advanced gastric cancer: too much of a good thing?

局部晚期胃癌的新辅助治疗是否过犹不及?

DiPeri, Timothy P; Gong, Jun; Burch, Miguel

Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery

前瞻性实施标准化肝切除术后护理路径以减少住院手术后阿片类药物处方量

DiPeri, Timothy P; Newhook, Timothy E; Arvide, Elsa M; Dewhurst, Whitney L; Bruno, Morgan L; Chun, Yun Shin; Tran Cao, Hop S; Lee, Jeffrey E; Vauthey, Jean-Nicolas; Tzeng, Ching-Wei D